Transduction of PACAP38 protects primary cortical neurons from neurotoxic injury

Neuroscience Letters

Volumn 448, Issue 1, 2008, Pages 52-55

  Sanchez, Alma ^a   Chiriva Internati, Maurizo ^b   Grammas, Paula ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

AAV; Neuronal cell death; Neurotrophic; PACAP38; Viral vector

Indexed keywords

ADENOVIRUS VECTOR; CAPSID PROTEIN; GREEN FLUORESCENT PROTEIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ANIMAL CELL; ARTICLE; BRAIN CELL; CELL SURVIVAL; CONTROLLED STUDY; DEGENERATIVE DISEASE; FETUS; FLUORESCENCE MICROSCOPY; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; NERVE CELL; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSGENE;

ANALYSIS OF VARIANCE; ANIMALS; CELL SURVIVAL; CEREBRAL CORTEX; EMBRYO, MAMMALIAN; FATTY ACIDS, MONOUNSATURATED; GREEN FLUORESCENT PROTEINS; INDOLES; NEURONS; NITRIC OXIDE DONORS; NITROPRUSSIDE; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; QUATERNARY AMMONIUM COMPOUNDS; RATS; TRANSDUCTION, GENETIC; TRANSFECTION;

EID: 55549092391     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.10.021     Document Type: Article

References (42)

1. Agrawal N., You H., Liu Y., Chiriva-Internati M., Bremner J., Garg T., Grizzi F., Krishna Prasad C., Mehta J.L., and Hermonat P.L. Generation of recombinant skin in vitro by adeno-associated virus type 2 vector transduction. Tissue Eng. 10 (2004) 1707-1715
2. Anderson S.T., and Curlewis J.D. PACAP stimulates dopamine neuronal activity in the medial basal hypothalamus and inhibits prolactin. Brain Res. 790 (1998) 343-346
3. Blacklow N.R., Hoggan M.D., Kapikian A.Z., Austin J.B., and Rowe W.P. Epidemiology of adenovirus-associated virus infection in a nursery population. Am. J. Epidemiol. 88 (1968) 368-378
4. Campbell R.M., and Scanes C.G. Evolution of the growth hormone-releasing factor (GRF) family of peptides. Growth Regul. 2 (1992) 175-191
5. Carty N.C., Nash K., Lee D., Mercer M., Gottschall P.E., Meyers C., Muzyczka N., Gordon M.N., and Morgan D. Adeno-associated viral (AAV) serotype 5 vector mediated gene delivery of endothelin-converting enzyme reduces Abeta deposits in APP + PS1 transgenic mice. Mol. Ther. 16 (2008) 1580-1586
6. Chiriva-Internati M., Liu Y., Weidanz J.A., Grizzi F., You H., Zhou W., Bumm K., Barlogie B., Mehta J.L., and Hermonat P.L. Testing recombinant adeno-associated virus-gene loading of dendritic cells for generating potent cytotoxic T lymphocytes against a prototype self-antigen, multiple myeloma HM1.24. Blood 102 (2003) 3100-3107
7. Dechant G., Neumann H., and Neurotrophins. Adv. Exp. Med. Biol. 513 (2002) 303-334
8. Eberling J.L., Jagust W.J., Christine C.W., Starr P., Larson P., Bankiewicz K.S., and Aminoff M.J. Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. Neurology 70 (2008) 1980-1983
9. Fukuchi K., Tahara K., Kim H.D., Maxwell J.A., Lewis T.L., Accavitti-Loper M.A., Kim H., Ponnazhagan S., and Lalonde R. Anti-Abeta single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease. Neurobiol. Dis. 23 (2006) 502-511
10. Girard B.M., Young B.A., Buttolph T.R., White S.L., and Parsons R.L. Regulation of neuronal pituitary adenylate cyclase-activating polypeptide expression during culture of guinea-pig cardiac ganglia. Neuroscience 146 (2007) 584-593
11. Grammas P., Moore P., and Weigel P.H. Microvessels from Alzheimer's disease brains kill neurons in vitro. Am. J. Pathol. 154 (1999) 337-342
12. Grieger J.C., Choi V.W., and Samulski R.J. Production and characterization of adeno-associated viral vectors. Nat. Protoc. 1 (2006) 1412-1428
13. Hashimoto H., Hagihara N., Koga K., Yamamoto K., Shintani N., Tomimoto S., Mori W., Koyama Y., Matsuda T., and Baba A. Synergistic induction of pituitary adenylate cyclase-activating polypeptide (PACAP) gene expression by nerve growth factor and PACAP in PC12 cells. J. Neurochem. 74 (2000) 501-507
14. Howard D.B., Powers K., Wang Y., and Harvey B.K. Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitro. Virology 372 (2008) 24-34
15. Kaplitt M.G., Feigin A., Tang C., Fitzsimons H.L., Mattis P., Lawlor P.A., Bland R.J., Young D., Strybing K., Eidelberg D., and During M.J. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 369 (2007) 2097-2105
16. Kim J., Yoon Y.S., Lee H., and Chang J.W. AAV-GAD gene for rat models of neuropathic pain and Parkinson's disease. Acta Neurochir. (Suppl.) 101 (2008) 99-105
17. Lindvall O., Kokaia Z., Bengzon J., Elmer E., and Kokaia M. Neurotrophins and brain insults. Trends Neurosci. 17 (1994) 490-496
18. Liu Y., Chiriva-Internati M., Grizzi F., Salati E., Roman J.J., Lim S., and Hermonat P.L. Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector. Cancer Gene Ther. 8 (2001) 948-957
19. Liu Y., Santin A.D., Mane M., Chiriva-Internati M., Parham G.P., Ravaggi A., and Hermonat P.L. Transduction and utility of the granulocyte-macrophage colony-stimulating factor gene into monocytes and dendritic cells by adeno-associated virus. J. Interferon Cytokine Res. 20 (2000) 21-30
20. Onoue S., Endo K., Ohshima K., Yajima T., and Kashimoto K. The neuropeptide PACAP attenuates beta-amyloid (1-42)-induced toxicity in PC12 cells. Peptides 23 (2002) 1471-1478
21. Passini M.A., Macauley S.L., Huff M.R., Taksir T.V., Bu J., Wu I.H., Piepenhagen P.A., Dodge J.C., Shihabuddin L.S., O'Riordan C.R., Schuchman E.H., and Stewart G.R. AAV vector-mediated correction of brain pathology in a mouse model of Niemann-Pick A disease. Mol. Ther. 11 (2005) 754-762
22. Pellegri G., Magistretti P.J., and Martin J.L. VIP and PACAP potentiate the action of glutamate on BDNF expression in mouse cortical neurones. Eur. J. Neurosci. 10 (1998) 272-280
23. Pettersson L.M., Dahlin L.B., and Danielsen N. Changes in expression of PACAP in rat sensory neurons in response to sciatic nerve compression. Eur. J. Neurosci. 20 (2004) 1838-1848
24. Pettersson L.M., Heine T., Verge V.M., Sundler F., and Danielsen N. PACAP mRNA is expressed in rat spinal cord neurons. J. Comp. Neurol. 471 (2004) 85-96
25. Rafi M.A., Zhi Rao H., Passini M.A., Curtis M., Vanier M.T., Zaka M., Luzi P., Wolfe J.H., and Wenger D.A. AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy. Mol. Ther. 11 (2005) 734-744
26. Reimann-Philipp U., Ovase R., Weigel P.H., and Grammas P. Mechanisms of cell death in primary cortical neurons and PC12 cells. J. Neurosci. Res. 64 (2001) 654-660
27. Sacchetti B., Lorenzini C.A., Baldi E., Bucherelli C., Roberto M., Tassoni G., and Brunelli M. Pituitary adenylate cyclase-activating polypeptide hormone (PACAP) at very low dosages improves memory in the rat. Neurobiol. Learn Mem. 76 (2001) 1-6
28. Segre G.V., and Goldring S.R. Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein-linked receptor family. Trends Endocrinol. Metab. 4 (1993) 309-314
29. Shaw G., Morse S., Ararat M., and Graham F.L. Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J. 16 (2002) 869-871
30. Shevtsova Z., Malik J.M., Michel U., Bahr M., and Kugler S. Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo. Exp. Physiol. 90 (2005) 53-59
31. Shintani N., Suetake S., Hashimoto H., Koga K., Kasai A., Kawaguchi C., Morita Y., Hirose M., Sakai Y., Tomimoto S., Matsuda T., and Baba A. Neuroprotective action of endogenous PACAP in cultured rat cortical neurons. Regul. Pept. 126 (2005) 123-128
32. Suarez V., Guntinas-Lichius O., Streppel M., Ingorokva S., Grosheva M., Neiss W.F., Angelov D.N., and Klimaschewski L. The axotomy-induced neuropeptides galanin and pituitary adenylate cyclase-activating peptide promote axonal sprouting of primary afferent and cranial motor neurones. Eur. J. Neurosci. 24 (2006) 1555-1564
33. Tenenbaum L., Chtarto A., Lehtonen E., Velu T., Brotchi J., and Levivier M. Recombinant AAV-mediated gene delivery to the central nervous system. J. Gene Med. 1 6 (Suppl) (2004) S212-S222
34. Tian Y.Y., Tang C.J., Wang J.N., Feng Y., Chen X.W., Wang L., Qiao X., and Sun S.G. Favorable effects of VEGF gene transfer on a rat model of Parkinson disease using adeno-associated viral vectors. Neurosci. Lett. 421 (2007) 239-244
35. Tripathi R.B., and McTigue D.M. Chronically increased ciliary neurotrophic factor and fibroblast growth factor-2 expression after spinal contusion in rats. J. Comp. Neurol. 510 (2008) 129-144
36. Uchida D., Arimura A., Somogyvari-Vigh A., Shioda S., and Banks W.A. Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide. Brain Res. 736 (1996) 280-286
37. Vaudry D., Hamelink C., Damadzic R., Eskay R.L., Gonzalez B., Eiden L.E., and Endogenous. PACAP acts as a stress response peptide to protect cerebellar neurons from ethanol or oxidative insult. Peptides 26 (2005) 2518-2524
38. Vaudry D., Rousselle C., Basille M., Falluel-Morel A., Pamantung T.F., Fontaine M., Fournier A., Vaudry H., and Gonzalez B.J. Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 6398-6403
39. Veldwijk M.R., Topaly J., Laufs S., Hengge U.R., Wenz F., Zeller W.J., and Fruehauf S. Development and optimization of a real-time quantitative PCR-based method for the titration of AAV-2 vector stocks. Mol. Ther. 6 (2002) 272-278
40. Wang L., Muramatsu S., Lu Y., Ikeguchi K., Fujimoto K., Okada T., Mizukami H., Hanazono Y., Kume A., Urano F., Ichinose H., Nagatsu T., Nakano I., and Ozawa K. Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease. Gene Ther. 9 (2002) 381-389
41. You H., Liu Y., Carey M.J., Lowery C.L., and Hermonat P.L. Defective 3A trophoblast-endometrial cell adhesion and altered 3A growth and survival by human papillomavirus type 16 oncogenes. Mol. Cancer Res. 1 (2002) 25-31
42. Zolotukhin S., Byrne B.J., Mason E., Zolotukhin I., Potter M., Chesnut K., Summerford C., Samulski R.J., and Muzyczka N. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6 (1999) 973-985